
1. rev prat. 2010 jan 20;60(1):81-92.

[the strategy influenza].

[article french]

labro mt(1), etiemble j.

author information: 
(1)centre d'expertise collective inserm, sc14, faculté de médecine xavier-bichat,
75870 paris cedex 18. marie-therese.labro@inserm.fr

in france, influenza kills 2,000 persons per year among viruses (m.
influenzae a, b c), type dangerous caused several
deadly epidemics. deepening knowledge mechanisms infection is
essential search new antiviral drugs effective vaccines,
particularly developing vaccine giving long-term immunity. april 2009, a
novel flu strain combined genes human, pig, bird flu, influenza
a/h1n1, emerged mexico, united states, several nations. 
officially declared outbreak pandemic june 11, 2009. 2003, 
emerging a(h5n1) influenza virus responsible largest epizootic
event described far. facing fear mutation recombination the
virus, pandemic threat strengthened public health device and
stimulated fundamental, clinical applied research. mobilization of
government scientific community beneficial onset pandemic 
a(h1n1). continues monitor a(h1n1) pandemics worldwide, based results
of clinical studies specific research.


pmid: 20222318  [indexed medline]

